Arbutus Biopharma Corporation (ABUS) DCF Valuation

Avaliação DCF de Arbutus Biopharma Corporation (ABUS)

US | Healthcare | Biotechnology | NASDAQ
Arbutus Biopharma Corporation (ABUS) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Arbutus Biopharma Corporation (ABUS) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Avalie as perspectivas financeiras da Arbutus Biopharma Corporation (abus) como um especialista! Essa calculadora (abus) DCF fornece dados financeiros pré-preenchidos e flexibilidade para modificar o crescimento da receita, o WACC, as margens e outras suposições críticas para se alinhar às suas projeções.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 6.0 6.9 11.0 39.0 18.1 23.6 30.7 40.0 52.0 67.6
Revenue Growth, % 0 15.02 58.92 255.11 -53.51 30.11 30.11 30.11 30.11 30.11
EBITDA -147.3 -57.8 -71.6 -61.9 -71.0 -23.6 -30.7 -40.0 -52.0 -67.6
EBITDA, % -2450.86 -836.07 -651.96 -158.54 -391.3 -100 -100 -100 -100 -100
Depreciation 2.0 2.0 1.8 1.4 1.4 4.2 5.5 7.2 9.3 12.1
Depreciation, % 33.74 28.61 15.95 3.66 7.74 17.94 17.94 17.94 17.94 17.94
EBIT -149.3 -59.8 -73.4 -63.3 -72.4 -23.6 -30.7 -40.0 -52.0 -67.6
EBIT, % -2484.59 -864.68 -667.91 -162.19 -399.04 -100 -100 -100 -100 -100
Total Cash 90.8 123.3 155.3 146.9 126.0 23.6 30.7 40.0 52.0 67.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.2 1.3 .9 1.4 1.8
Account Receivables, % 20.03 18.98 8.18 3.46 9.79
Inventories .0 -3.1 -4.4 -2.9 .0 -4.4 -5.7 -7.4 -9.7 -12.6
Inventories, % 0 -45.18 -40.45 -7.37 0 -18.6 -18.6 -18.6 -18.6 -18.6
Accounts Payable 2.4 3.0 3.2 3.5 3.2 6.6 8.5 11.1 14.4 18.8
Accounts Payable, % 39.89 43.3 28.89 9.02 17.77 27.77 27.77 27.77 27.77 27.77
Capital Expenditure -.6 -.2 -.8 -.5 -1.0 -1.3 -1.7 -2.2 -2.8 -3.7
Capital Expenditure, % -9.8 -3.31 -7.36 -1.31 -5.56 -5.47 -5.47 -5.47 -5.47 -5.47
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -138.0 -61.2 -74.5 -67.6 -72.4 -23.2 -30.2 -39.3 -51.2 -66.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -135.4 -55.8 -71.6 -68.4 -75.6 -13.7 -24.0 -31.2 -40.6 -52.8
WACC, % 12.28 12.29 12.29 12.29 12.29 12.29 12.29 12.29 12.29 12.29
PV UFCF
SUM PV UFCF -108.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -54
Terminal Value -524
Present Terminal Value -293
Enterprise Value -402
Net Debt -18
Equity Value -384
Diluted Shares Outstanding, MM 166
Equity Value Per Share -2.31

What You Will Receive

  • Comprehensive Financial Model: Leverage Arbutus Biopharma's actual data for accurate DCF valuation.
  • Complete Forecasting Flexibility: Modify revenue growth, profit margins, WACC, and other critical factors.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you adjust inputs.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Adaptable and Reusable: Designed for versatility, allowing ongoing use for in-depth forecasting.

Key Features

  • 🔍 Real-Life ABUS Financials: Pre-filled historical and projected data for Arbutus Biopharma Corporation (ABUS).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Arbutus Biopharma’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Arbutus Biopharma’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template containing Arbutus Biopharma Corporation’s (ABUS) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Arbutus Biopharma Corporation’s (ABUS) intrinsic value.
  • Step 5: Utilize the outputs to make informed investment decisions or create comprehensive reports.

Why Choose This Calculator?

  • Accuracy: Utilizes authentic Arbutus Biopharma financials to guarantee data precision.
  • Flexibility: Built for users to easily experiment and adjust inputs as needed.
  • Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users with varying levels of financial modeling skills.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for analyzing Arbutus Biopharma Corporation (ABUS).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Offer clients precise valuation insights related to Arbutus Biopharma Corporation (ABUS) stock.
  • Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Arbutus Biopharma Corporation (ABUS) are valued in the market.

What the Template Contains

  • Pre-Filled DCF Model: Arbutus Biopharma Corporation’s (ABUS) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Arbutus Biopharma Corporation’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.